• Home
  • Pharmaceuticals and Healthcare
Global Next-Generation Sequencing (NGS) Kits Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Next-Generation Sequencing (NGS) Kits Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Report Code: KNJ1028318 | No. of Pages: 128 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Nov-2021 
Executive Summary

According to GRD Survey data, the global Next-Generation Sequencing (NGS) Kits market was valued at  million US$ in 2020 and is expected to reach  million US$ by the end of 2027, growing at a CAGR of % in the forecast period between 2021 and 2027.

This report studies the Next-Generation Sequencing (NGS) Kits market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Next-Generation Sequencing (NGS) Kits in these regions, from 2016 to 2027, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
    Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
    South America (Brazil, Argentina, Colombia, etc.)
    Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
    BRCA

    EGFR

    BRAF

    Others

Market Snapshot, By Application
    Hospitals and Clinics

    Biopharma Companies

    Research Organizations

    Others

Main Market Players Analyzed in this report, including:
    Thermo Fisher Scientific

    Novogene

    Nanjing Geneseeq

    MSKCC

    Illumina

    Foundation Medicine

    Burning Rock Biotech

    Amoydxmed


The study objectives of this report are:
    To study and analyze the global Next-Generation Sequencing (NGS) Kits market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
    To understand industry structure of Next-Generation Sequencing (NGS) Kits market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To identify the key global Next-Generation Sequencing (NGS) Kits manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Next-Generation Sequencing (NGS) Kits market with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Next-Generation Sequencing (NGS) Kits submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Next-Generation Sequencing (NGS) Kits are as follows:
    History Year: 2016-2020
    Base Year: 2020
    Estimated Year: 2021
    Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1  Market Definition & Scope
    1.1  Definition & Scope
    1.2 Next-Generation Sequencing (NGS) Kits Product Specifications
    1.3  Main Events (Entry, M&A, Exit, Technology and Capital Activity)
    1.4 Global Next-Generation Sequencing (NGS) Kits Market Performance and Outlook

2 Market Development Performance under COVID-19
    2.1 Influencing Factors of Industry Development in the Next Five Years
        2.1.1 Drivers
        2.1.2 Restraints
        2.1.3 Opportunities
    2.2 Porter’s Five Forces Analysis
    2.3 Comparison of Alternatives and Next-Generation Sequencing (NGS) Kits

3 Supply Chain and Manufacturing Cost Analysis
    3.1 Supply Chain Analysis
    3.2 Raw Materials and Key Suppliers Analysis
        3.2.1 Raw Materials Introduction
        3.2.1 Raw Materials Key Suppliers List
    3.3 Next-Generation Sequencing (NGS) Kits Sales Channel and Distributors Analysis
        3.3.1 Next-Generation Sequencing (NGS) Kits Sales Channel
        3.3.2 Next-Generation Sequencing (NGS) Kits Distributors
    3.4 Key Buying Industries/Consumers
        3.4.1 Major Buyers in Hospitals and Clinics

        3.4.2 Major Buyers in Biopharma Companies

    3.5 Next-Generation Sequencing (NGS) Kits Manufacturing Cost Structure Analysis

4 Market Segment: by Type
    4.1 Next-Generation Sequencing (NGS) Kits Type Introduction
        4.1.1 BRCA

        4.1.2 EGFR

        4.1.3 BRAF

        4.1.4 Others
    4.2 Global Next-Generation Sequencing (NGS) Kits Sales by Type 2016-2021
    4.3 Global Next-Generation Sequencing (NGS) Kits Revenue by Type 2016-2021
    4.4 Global Next-Generation Sequencing (NGS) Kits Price by Type 2016-2021

5 Market Segment: by Application
    5.1 Next-Generation Sequencing (NGS) Kits Type Introduction
        5.1.1 Hospitals and Clinics

        5.1.2 Biopharma Companies

        5.1.3 Research Organizations

        5.1.3 Others
    5.2 Global Next-Generation Sequencing (NGS) Kits Sales by Application 2016-2021
    5.3 Global Next-Generation Sequencing (NGS) Kits Revenue by Application 2016-2021
    5.4 Global Next-Generation Sequencing (NGS) Kits Price by Application 2016-2021

6 Marke Segment: by Region
    6.1 Global Next-Generation Sequencing (NGS) Kits Market by Region
        6.1.1 Global Next-Generation Sequencing (NGS) Kits Sales by Regions
        6.1.2 Global Next-Generation Sequencing (NGS) Kits Revenue by Regions
    6.2 North America Next-Generation Sequencing (NGS) Kits Market 2016-2021
    6.3 Europe Next-Generation Sequencing (NGS) Kits Market 2016-2021
    6.4 Asia Pacific Next-Generation Sequencing (NGS) Kits Market 2016-2021
    6.5 South America Next-Generation Sequencing (NGS) Kits Market 2016-2021
    6.6 Middle East and Africa Next-Generation Sequencing (NGS) Kits Market 2016-2021

7 North America
    7.1 North America Next-Generation Sequencing (NGS) Kits Market by Country 2016-2021
        7.1.1 North America Next-Generation Sequencing (NGS) Kits Sales by Country
        7.1.2 North America Next-Generation Sequencing (NGS) Kits Revenue by Country
    7.2 United States
    7.3 Canada
    7.4 Mexico

8 Europe
    8.1 Europe Next-Generation Sequencing (NGS) Kits Market by Country 2016-2021
        8.1.1 Europe Next-Generation Sequencing (NGS) Kits Sales by Country
        8.1.2 Europe Next-Generation Sequencing (NGS) Kits Revenue by Country
    8.2 Germany
    8.3 France
    8.4 UK
    8.5 Italy
    8.6 Russia
    8.7 Spain

9 Asia Pacific
    9.1 Asia Pacific Next-Generation Sequencing (NGS) Kits Market by Country 2016-2021
        9.1.1 Asia Pacific Next-Generation Sequencing (NGS) Kits Sales by Country
        9.1.2 Asia Pacific Next-Generation Sequencing (NGS) Kits Revenue by Country
    9.2 China
    9.3 Japan
    9.4 Korea
    9.5 Southeast Asia
    9.6 India
    9.7 Australia

10 South America
    10.1 South America Next-Generation Sequencing (NGS) Kits Market by Country 2016-2021
        10.1.1 South America Next-Generation Sequencing (NGS) Kits Sales by Country
        10.1.2 South America Next-Generation Sequencing (NGS) Kits Revenue by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Colombia

11 Middle East and Africa
    11.1 Middle East and Africa Next-Generation Sequencing (NGS) Kits Market by Country 2016-2021
        11.1.1 Middle East and Africa Next-Generation Sequencing (NGS) Kits Sales by Country
        11.1.2 Middle East and Africa Next-Generation Sequencing (NGS) Kits Revenue by Country
    11.2 Turkey
    11.3 Saudi Arabia
    11.4 South Africa

12 Key Participants Company Information
    12.1 Thermo Fisher Scientific

        12.1.1 Thermo Fisher Scientific
 Company Information
        12.1.2 Thermo Fisher Scientific
 Next-Generation Sequencing (NGS) Kits Product Portfolio, Specification and Application
        12.1.3 Thermo Fisher Scientific
 Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2019-2021)
        12.1.4 Thermo Fisher Scientific
 Key Development
    12.2 Novogene

        12.2.1 Novogene
 Company Information
        12.2.2 Novogene
 Next-Generation Sequencing (NGS) Kits Product Portfolio, Specification and Application
        12.2.3 Novogene
 Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2019-2021)
        12.2.4 Novogene
 Key Development
    12.3 Nanjing Geneseeq

        12.3.1 Nanjing Geneseeq
 Company Information
        12.3.2 Nanjing Geneseeq
 Next-Generation Sequencing (NGS) Kits Product Portfolio, Specification and Application
        12.3.3 Nanjing Geneseeq
 Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2019-2021)
        12.3.4 Nanjing Geneseeq
 Key Development
    12.4 MSKCC

        12.4.1 MSKCC
 Company Information
        12.4.2 MSKCC
 Next-Generation Sequencing (NGS) Kits Product Portfolio, Specification and Application
        12.4.3 MSKCC
 Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2019-2021)
        12.4.4 MSKCC
 Key Development
    12.5 Illumina

        12.5.1 Illumina
 Company Information
        12.5.2 Illumina
 Next-Generation Sequencing (NGS) Kits Product Portfolio, Specification and Application
        12.5.3 Illumina
 Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2019-2021)
        12.5.4 Illumina
 Key Development
    12.6 Foundation Medicine

        12.6.1 Foundation Medicine
 Company Information
        12.6.2 Foundation Medicine
 Next-Generation Sequencing (NGS) Kits Product Portfolio, Specification and Application
        12.6.3 Foundation Medicine
 Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2019-2021)
        12.6.4 Foundation Medicine
 Key Development
    12.7 Burning Rock Biotech

        12.7.1 Burning Rock Biotech
 Company Information
        12.7.2 Burning Rock Biotech
 Next-Generation Sequencing (NGS) Kits Product Portfolio, Specification and Application
        12.7.3 Burning Rock Biotech
 Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2019-2021)
        12.7.4 Foundation Medicine
 Key Development
        12.8.1 Amoydxmed
 Company Information
        12.8.2 Amoydxmed
 Next-Generation Sequencing (NGS) Kits Product Portfolio, Specification and Application
        12.8.3 Amoydxmed
 Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2019-2021)
        12.8.4 Amoydxmed
 Key Development

13 Global Next-Generation Sequencing (NGS) Kits Market Forecast by Region by Type and by Application
    13.1 Global Next-Generation Sequencing (NGS) Kits Sales, Revenue Forecast 2022-2027
    13.2 Global Next-Generation Sequencing (NGS) Kits Forecast by Regions
        13.2.1 Global Next-Generation Sequencing (NGS) Kits Sales Forecast by Region 2022-2027
        13.2.2 Global Next-Generation Sequencing (NGS) Kits Revenue Forecast by Region 2022-2027
    13.3 Global Next-Generation Sequencing (NGS) Kits Forecast by Type
        13.3.1 Global Next-Generation Sequencing (NGS) Kits Sales Forecast by Type 2022-2027
        13.3.2 Global Next-Generation Sequencing (NGS) Kits Revenue Forecast by Type 2022-2027
        13.3.3 Global Next-Generation Sequencing (NGS) Kits Price Forecast by Type 2022-2027
    13.4 Global Next-Generation Sequencing (NGS) Kits Forecast by Application
        13.4.1 Global Next-Generation Sequencing (NGS) Kits Sales Forecast by Application 2022-2027
        13.4.2 Global Next-Generation Sequencing (NGS) Kits Revenue Forecast by Application 2022-2027
        13.4.3 Global Next-Generation Sequencing (NGS) Kits Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
    15.1 Methodology
    15.2 Research Data Source
        15.2.1 Secondary Data
        15.2.2 Primary Data
        15.2.3 Market Size Estimation
    15.3 Legal Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com